Manufacturers in India are gearing up to produce generic versions of Pfizer and Merck’s antivirals and can make millions of pills a month. They just need regulators to give them the okay.
Manufacturers in India are gearing up to produce generic versions of Pfizer and Merck’s antivirals and can make millions of pills a month. They just need regulators to give them the okay.